Streetbeat News

TIVC

Tivic Health Systems, Inc.

https://www.tivichealth.com

Industry

Medical - Devices

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Open

0.30

Mkt cap

1.8M

Volume

2.2M

High

0.31

P/E Ratio

0.02

52-wk high

3.21

Low

0.25

Div yield

N/A

52-wk low

0.22

Tivic Health Systems, Inc. (Nasdaq: TIVC) announced its third quarter 2024 financial results and discussed growth strategies focused on its vagus nerve stimulation technology.

Portfolio Pulse from

November 15, 2024 | 5:00 am

Tivic Health Systems, Inc. (TIVC) held its Q3 2024 earnings call, providing financial results and operational updates. The call was pre-recorded, and pre-submitted questions were addressed.

Portfolio Pulse from

November 14, 2024 | 11:30 pm

Tivic Health Systems has enrolled the first subject in a study for its non-invasive vagus nerve stimulation device. The study aims to optimize device parameters and will be completed by December.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 12:12 pm

Several healthcare stocks experienced significant price movements during Wednesday's intraday session. Notable gainers included Nuwellis, Streamline Health Solutions, and Inhibikase Therapeutics, while Windtree Therapeutics and Ontrak were among the biggest losers.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 4:31 pm

In Wednesday's pre-market session, several healthcare stocks experienced significant price movements. Notable gainers include Carmell (CTCX), Clearside Biomedical (CLSD), and Kezar Life Sciences (KZR), while Nexalin Technology (NXL) and Tivic Health Systems (TIVC) were among the losers.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 12:07 pm

In Tuesday's after-market session, several healthcare stocks experienced significant price movements. Kezar Life Sciences (KZR) led the gainers with a 28.2% increase, while Nexalin Technology (NXL) saw the largest decline, dropping 14.7%.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 8:31 pm

Several healthcare stocks experienced significant price movements in Monday's after-market session. Vincerx Pharma, Oragenics, Avidity Biosciences, Tivic Health Systems, Verrica Pharmaceuticals, and Immunome saw gains, while LogicMark, Trevena, Soligenix, Mainz Biomed, Kairos Pharma, and Cue Biopharma experienced declines.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 8:31 pm

In Wednesday's pre-market session, several healthcare stocks experienced significant movements. Eterna Therapeutics, ModivCare, Cardio Diagnostics, Autolus Therapeutics, Beyond Air, and Meihua Intl Medical Techs saw notable gains. Conversely, Humana, Carmell, Tivic Health Systems, Kairos Pharma, IGM Biosciences, and Silexion Therapeutics experienced declines.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 12:05 pm

Tivic Health has received Institutional Review Board approval for its ncVNS optimization study, which is a step towards advancing its personalized non-invasive vagus nerve stimulation technology. The company is preparing for enrollment in the study.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 1:07 pm

Tivic Health Systems' stock is rising following its partnership with Fletcher Spaght to enhance its commercial strategy for non-invasive cervical vagus nerve stimulation.

Portfolio Pulse from Benzinga Newsdesk

September 17, 2024 | 1:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.